MedTech News
.................... by Andrew Celentano
Lab-designed molecule offers hope for celiac disease sufferers
A research project led by the Institute for Research in Nutrition and Food Safety (INSA) and the Faculty of Pharmacy and Food Sciences at the University of Barcelona, together with the Molecular Biology Institute of Barcelona (IBMB) of the CSIC (which stands for Consejo Superior de Investigaciones Científicas), has successfully designed and tested a gluten-degrading molecule that is a promising ally in the management of celiac disease, an autoimmune
AI platform decodes how cells ‘talk’ in cancer, Alzheimer’s and other complex diseases
Scientists at Houston Methodist have developed an artificial intelligence platform that can decode how cells communicate inside the human body, opening a window into conditions such as Alzheimer’s disease, cancer, and potentially accelerating the search for new treatments.
AI Retinal Scans May Help Predict Osteoporosis Risk Before Fractures Occur
A routine eye scan might reveal more than whether or not someone needs glasses. It could also help doctors spot signs of osteoporosis years before a broken bone ever happens.
Contact Lenses Using Tiny Electrical Signals Could Target Brain Regions to Ease Depression
Mice treated with special contact lenses experienced antidepressant-like effects comparable to Prozac after only three weeks.
Revvity secures FDA clearance for total testosterone immunoassay
The assay enables ChLIA measurement of testosterone markers, delivering diagnostic capabilities for suspected male hypogonadism.
Sonomotion wins updated FDA nod for lithotripsy device for kidney stones, trial meets endpoints
SonoMotion announced today that the company picked up updated FDA clearance for its Break Wave lithotripsy platform.
Researchers successfully treat hereditary epilepsy in a mouse model
In a world first, a research team at the University of Zurich has successfully treated mice carrying an inherited form of epilepsy.
Simple blood test could help spot dementia risk earlier by combining aging and genetic clues
The study, published in Alzheimer’s & Dementia, showed that having a biological age older than chronological age is associated with a greater likelihood of developing dementia, particularly vascular dementia, and with an earlier age of onset across dementia subtypes.